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To study the role of IFN-1' in the pathogenesis of 
inflammatory skin diseases, we used the involucrin 
promoter to overexpress IFN-1' in the suprabasal 
layers of transgenic mouse epidermis. IFN-1' mRNA 
and protein were readily detectable in the skin but 
not in the blood. Mice exhibited striking hypopig-
mentation of the hair due to a reduced abundance of 
DOPA-positive melanocytes. Severely affected mice 
had reddened skin, growth retardation, hair loss, and 
flaky skin lesions. Keratinocyte proliferation was in-
creased. and there was epidermal thickening with 
spongiosis and parakeratosis. Suprabasal (31 integrin 
expression and induction ofkeratill 17 in interfollicu-
lar epidermis provided evidence of perturbed differ-
entia tion. IFN-1' receptor expression was reduced, 
and there was induction ofICAM-1 and MHC class II 
E czema, or dermatitis, is a gen eral term that describes an inflammation of the skin (Hopkins and C lark, 1995). In con tact dermatitis the inflamm atory stimulus ca n be provided by exposure to a wide variety of agents in the environm en t: examples in cl ude urushio l, the in'itant 
fo und in poison ivy, and ni ckel, found in j ewelery. Wh en skin has 
becom c sensitizcd to a ch emical that cau ses contact dermatiti s, 
subsequ en t exposure can lead to a major histocompatabili ty com-
plex (MHC)-restrictcd , hapten-specific T cell response known as 
co ntact hypersensitivity o r aUergic contact dermatitis (Enk and 
Katz, J 995). 
In con tact dermati ti s there are ch an ges in both epidermis and 
dermis. T h e epidermis becomes thicken ed, and terminal diffe ren-
tiation is perturbed , with nucl e i retained in the cornified cells; there 
is a lso characteristic spo ngiosis (intercellular edema) resul ting fi'om 
an accumulation of Ruid in the inte rcellular spaces. The dermis 
becom es infiltrated by lymph ocytes and monocytes; there is dil ation 
of th e blood vessels and dermal edema (Hopkins and C lark , 1995). 
The pathogenesis of contact dermatitis is not understood, bu t 
cytokinc rclease by lymphocytes and keratinocytes is believed to 
pl ay an impo rtant ro le (reviewed by McKenzie and Sauder, J 990; 
Barker ('( Il l , 1991) . .ln terfero n-y (rFN-y) is a so luble cytokine 
Manuscript received November 20, 1996; rcvised January 13, '1997; 
accepted for publicarion January 17, 1997. 
P. .. eprint requests to: Dr. Fiona M. Watt. Imperial Cancer Research Fund 
Keratillocytc Laboratory, P.O. nox 123. Lincol,, 's Inn Fields, London 
WC2A 3J>X. U.K. 
molecules on the surface oftrallsgenic keratinocytes. 
The skin of severely affected mice was characterized 
by a dermal infiltrate of T lymphocytes and macro-
phages/monocytes, but the epidermis was almost de-
void of Langerhalls cells and T lymphocytes. The 
number of Langerhans cells in the lymph nodes was 
increased in the transgenics, and autoantibodies to 
keratinocytes were produced. Transgenic mice 
showed an increased contact hypersensitivity reac-
tion to topical application of DNFB. We conclude 
that constitutive IFN-1' expression in the epidermis 
results in a form of eczema resembling contact d er-
matitis and in a profound contact hypersensitivity 
reaction. K ey Ivords: IFN-I'/trallsgellic mice/ epidermis! 
mela1locyteslJwMilljtammation. ] 111 vest Del'JlJatol 108:412-
422, 1997 
produced by activa ted T lymphocytes that is a potent m odulator of 
T lymph ocyte-medi ated immune respo nses (reviewed by Williams 
e/ III, 1993). IFN-y is known to indu ce expression of illtcrcellular 
adhesio n m o lecule-l (ICAM-l) and human Icukocyte antigen-DR, 
a product of the MHC class II locus, on thc surface ofkcratinocytes 
(Dustin e/ ai, 1988; Barker e/ ai, 1989; Barker c/ ai, 1990). Human 
le u kocyte antigen-DR and ICAM-J are expressed by keratinocytes 
in many infl ammatory skin diseases (Aubock e/ nl, 1986), and these 
m olecul es ;lre postul ated to stimul ;l te recruitment of lymphocytes 
to sites of epidermal inRa111matio n , ICA M-l acting as a counter-
receptor for LFA-l on lymphocytes (Dustin e/ ai , J 988; Nickoloff 
and T urka, 1994). 
Inj ection ofIFN-y into human volunteers has esta blished that tile 
cytokin e c;m indu ce tJ'ansient skin inflammation (Barker c/ nl, 1989, 
1990, 1993), but there has been n o experimcntalm odel to evaluate 
chronic overexpress io ll in the ski n . In order to obtain a fuller 
understanding of the role of I FN-y in skin inflamm ation , we have 
constitutively over-expressed IFN- ,), in the supra basal layers of the 
epidermis of transgeni c mice. 
MATEIUALS AND METHODS 
Transgcne Construction and Preparation ofTc'Ulsgenic Mice The 
cD NA for murine IFN-')' (kindly provided by Nora S;l\'vetnick) was excised 
fro 111 the vector pSVEmu,), as an EwRJI Ball/HI fragment (Gray and 
Gocddcl. J 983; Sarvetnick c( ai, '/ 988), blunt-ended. and ligated to Norl 
linkers. The cDNA was then c10lled in to the invollicrin expression plasm.id 
I-l3700-pL2 (Carroll e( al. ·1993) . T he transgcnc was excised from the 
expression plasmid by cutting with Sa II . purified as described previously 
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(CarroU et ai, 1993). and resuspcnded in steri le PI3S at a conccntration of 5 
/J.g per ml for oocyte injection. 
T he transgcnc was injccwd into fcrti li zed oocytes frol11 (CI3A X C571 
BL10) Fl micc as described prev io usly (Carroll ci ai, 1995). Animals were 
screened for the prese nce of the transgc llc using polynlcrasc chain reactio n 
of ear DNA with transgcnc-specific primers (one primer specific fo r SV40 
intronic sequenccs. the other specific fo r the 5 ' end of the IFN-y genc). 
Copy number was determined by Southcrn blotting as dcsc ribed previously 
(Carroll el ai, 1995). cxcept that the genomic DNA was iso la ted from mousc 
tail sn.ips and digested with HilldU II Ew RV. 
III Sit" Hybridization Skin samples wcre fixed in 4°/.) parafo nnaldehydc, 
debydrated , and cmbedded in parafrin . III Silll hybridization was carried out 
essentially as described (Hodivala and \Va tt, 1994) . T hc J5S- labclcd ribo-
probe to IFN-y was a polymcrase chain reaction-amplified 300-bp fragmcnt 
(base pairs 195-495) of murine IFN-y eD NA fro III the plasmid pSVEmuy 
(Gray and Gocddcl. 1983) cloned into pGEM3 . T he K17 probe was kindl y 
provided by P. Coulombc UolUls H opkim Universi ty, l3altimore, MD) , and 
the /3-actin probe was a gift of R. Po ulsom (Zandvliet el al . '( 996). 
Antibodics T he fo llowing primary antibodies we re used: MB 1.2 (rat 
anti-mouse /3) integrin; kindl y provided by Bosco Chan. University of 
Western Ontario , London. Ontario. Canada; von l3allestrcm cl ai, 1996); 
2E2, (hamstcr anti-mouse IFN-y receptor, a -chain; kindly providcd by R. 
Schreiber, Washington University. St. Louis. MO) ; NLDC-145 (rat anti-
DEC 205; rat monoclonal that rccognizes non lymphoid dcndritic cells 
including Langerhans cells; kindl y provided by J. Austyn, Oxford Univer-
sity, Oxford, England, UK; Kraal ci (/1. 1986; Jiang el al . ( 995); rabbit 
anti-Ki67 (Novacastra . Pe terborough, England , UK); anti B7-1; anti-CDS-
fluorosce in iso thiocyanate (FITC), anti-CD3 (unconjugated or FITC con-
jugated) , anti-CD11 b; anti-I CAM-l ; phycoerythrin (PE)-conjugatcd an ti-
C D4; and anti- IFN-y-FITC (all 6'0 111 Phamlingen, San Dicgo, CAl. MHC 
class II was detected with a combination of antibodies to IA and IE 
(Pharmingen). Keratins were detectcd using the antibodics described by 
Carroll el al. 1995. Secondary antibodies were purchased from Jackson 
Laboratories (Westgrove, PAl or DAKO (High Wycombe, England, UK). 
Histology, Immunocytochcmistry, and Dihydroxyphcnylalaninc 
(DOPA) Staining Tissucs from transgenic an imals and age-. sex-, and 
body site-matched ncgative control li ttennates werc used for all studies. For 
ro utine h.istology, tissues were fixed ovcrnight in fo rmol-sa linc. cmbeddcd 
in parafri n , and stained with hcmatoxylin and eosin. 
For inlnllllloAuoresccncc stainjng. tisslIes w e re snap-frozen in OCT ill an 
isopentane bath cooled in liquid nitrogen. Frozen sections were cut at 8 /J.m 
thickness . Sections were air-dried . fixed for '10 min in ace tone (room 
tc mperature) , air-dried. and blocked with 5% fctal bovine serum in I'I3S. 
After washing in PBS, scctions were incubated with p,-imary antibody, 
wasbed, and incubated with the appropriate fluorescein-conjugated second-
ary antibody. Sta ined slides were mounted in Ge lvato l and pho tographed . 
Ki-67 was visua li zcd by staining paraffin-embedded scctions of back skin. 
Rehydrated sec tions were then placed in a 0.01 M sodium citrate solu tion 
and boiled in a 700 W microwavc oven for '10 min. Aftc r rinsing in PI3S , 
slides were blocked with 5% FBS and then reacted with rabbit an ti-Ki67 
antibody. Slides were washed and incubated with anti-rabbit horse radish 
peroxidasc. Staining was visualised with 3,3' -di,"n inobenzidine tetrahydro-
chloride using the ABC kit (Vector Laboratories, Burlingame. CAl. To 
assess numbers of positive ccll s, groups of 200 basal ce lls werc counted in 
tripli cate fro m four difrerent slides of th e satne rnousc, and these l1uI11bcrs 
were averaged. Slides fi'om at least three micc from each line were countcd, 
a nd each va lue given in R es ults is fro ll1 a single rcprcscnt~tivc In O liSC . 
In order to visua lize melanocytes, frozen sections fi'om transgcnic and 
contro l mice of vario us ages were air-dried. ~ixcd in 41X, fa nna l-saline. 
washed in PI3S , and incubated with 0.'1% DL-DOPA for 6 h at 37°C. After 
washing thoroughly. slides were counter-stained with hematoxylin . 
E lectron Microscopy Skin samples were fixed in 2.5% glu taraldehyde in 
Sorensen' s buffe r. pH 7.4. post-fixed in I 'Yo osmium teu'oxide in the same 
buller, and embedded in ara ldite . Sections were cut on a R.eich<!1't U ltracut, 
stained with manyl acetate and lead citrate, and viewed in a Zeiss EM 10 
C R . 
Enzymc-Linkcd 1111111unosorbcnt Assay Mous!! serum. plasma , or 
extracts prcpared by sonica tion of 2_cm2 pieces of back skin in 0.5 ml 
p hosphate-buffered saline (PBS) and 0.2 mM phenylmcthylsulfonyl Auoride 
werc ana lyzed using a murine IFN-y Cytosereen immuno<:ssay kit (3io-
Sourcc Intl .. Camarillo. TX). R ecombinant mouse IFN-y (GcnzY111e, 
Cambridge, MA) in the range of 5-500 pg pCI' ml was used to standardize 
fo r known amounts of protein. Experiments were pcrfo rmed in tripli ca te 
(i.e. three J11i cc per fou nder Huc), and chro rn ogc lli c results 'we re read on a 
spectrophotometer at OD 45'" 
IFN-y EX PllESS ION IN TRANSGEN IC MOUSE EPID ERMI S 413 
T he ELISA was also used to measure IFN-y production by primary 
kcratinocytes that had been isola ted from mo use skin as described by Carroll 
el al (1995) and cultured as described for human keratinocytes Oones and 
Watt. 1993) with the exccption tl,at thc culturcs wcrc maintaincd at 32°C . 
Flow Cytol11ctry Cells wcre harvestcd and staincd using anri-CDS-
FITC, anti-CD3- FITC, or anti-CD4-PE. In somc cases . cells were staincd 
using NLDC-1 45, fo llowcd by goat anti-rat FITC (Cal tag, San Francisco. 
CA). Cell suspensions were incubatcd with monoclonal antibodies for 40 
min in 4°C in 100 /J.I Dulbecco's modified Eagle's medium containing 2% 
feta l bovine se rum and a .1'X, sodium azide. Cells werc washed with this 
medium betwecn incubations and before analysis on a FACScan (Becton 
Dickinson, Franklin Lakes. NJ ). Evcnts werc collected in I.ist mode and data 
were ana lyzed using Cell Quest software (Bccton Dickinson). Livc cells 
were gated according to their forward and side scatter profiles. Flow 
cytomerry of fixcd and permeabilized epidermal ce lls labe led with an 
FITC-conjugated antibody to IFN-')' was pcrformed cssenti all y as described 
by Vikingson el al (1 994). 
Ear Sensitization Groups of eight u'ansgenic mice and eight littennatc 
contro ls bct"\.vccn 8 and 12 \vk of age \ve rc used for these cxperilll c lltS. The 
abdominal surface of each mouse was shaved . and 50 /J.I of either 0 .5% 
2,4-dinitrofl uorobcnzcne (DNFI3; Sigma C hcmical Co_ St. Louis. MO) in 
acctOne/oli ve oil (3: 1) (four animals per group) or acetonc/ olive oi l vchicle 
alone (four animals per group) was app li ed. Five da ys later. ear thickness 
was measured before applying 20 ILl of 0.25% DNFB in acetonc /oli ve oil to 
cvery animal. Ear th.ickness was mcasured 6 h later. and each da y for tl, e 
next 4 d using a digita l engineer's micromcter (Mimtoya . UK Ltd .. 
Shefrield , England. UK). Ear thickness wa s averaged from va lues obtained 
at three different sitcs on each ear. 
RESULTS 
IFN-y Is Expressed in the Epidermis of Transgenic Mice 
T hree independent found e r lines of tran sgenic mice expressing 
mouse IFN-y under the contro l of the human involucrin promo ter 
were es tablished. Tra n sgene cop y number varied between the lines: 
12050 con ta ine d two copies, 1205C containe d six copies. and 
12 12F co n tained 32 copies. The phenotyp e of the animals did not 
vary b e tween founders , although [he proportion of severely af-
fec ted animals was highest in the 12 12F line. 
In order to d e termine whether the transgene w as conectly 
expressed, w e carri ed out ;11 S;11I h ybridiz ation analysis of skin from 
various body sites of Fl animals or anima.ls fi'om later gen e rations . 
IFN-y mRNA was detec te d in the supra basa l laye rs of keratino-
cytes in interfollicul ar e pid e rmis and in the inn e r root sh eatll of the 
h air follicles (Fig Ia,b), consistent with ti,e known sites of activity 
of the involucrill promote r (Carroll ef nl. 1993) . In some regions of 
the e pidermis, suprabasa l fFN-y mR..NA expression was patch y 
(Fig 111), in contrast to the uniform actin mRNA expression 
observed in adjacent sec tions (Fig Ie). Patc h y express ion was 
observed in the two lin es that we examined (1 2050 , 1205C) and 
in several mi ce from each lin e; thi s suggests that it was not du c 
to mosai c ism , but to post-transc ripti ona l regu lation of th e 
transge n e. 
Expression of IFN-y protein w as a lso eva luated. u sing two 
techniques: ELISA and flow cytolllctry. For the ELISA, 2-cm 2 
reg ions of back siGn were sonicated in 0.5 ml of buffe r and tile 
IFN- ')' contcnt of the supcrnatants was d e termined . Although 
extrac tion by this method is like ly to be in compl ete, IFN-y w as 
readily detec ted in sonica ted skin of transgenic mice fi'om all thrce 
found er lines: 6 ± 0.8 pg/cm 2 in 12050, 10 ± 2 pg/cm 2 in 1 20 5C, 
and 33 ± 8 pg/cm 2 in 1212F. No IFN-')' was d e tecte d in th e skin 
of con tro l li tte rmates o r in the serum or plasma of any o f t.he 
transgenic mice (limit of d etection in the assay: 5 pg per ml) . W h en 
keratinocytes were c ulturcd from n ormal and tran sgenic mouse 
skin, I FN-y was detected by ELISA in the m · dium of th e transge nic 
but not the contro l cell s (6-20 ng pCI' ml in medium conditione d 
for 24 h by conflu ent keratinocytes from line 12050). 
For flow cytome try, e pide rmal ke ratinocytes fi'om contl'o l o r 
transgenic mice wcre isolated , perme abilized. and labeled w ith an 
antibody to IFN-y. Keratinocytes with the forward and side sca tter 
charac teri sti cs of suprabasa l. differentiating cell s (sec Jones and 
Watt, 1993) were positive ly labele d, w h ereas basa l, undiffe re nti-
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Log INFy Fluorescence 
Figure 1. Transgenic keratinocytes express IFN-,),. (n-c) III sifll hybrid ization of transgenic do rsa l skin of a 14-d mouse from line 120SC using probes 
to IFN-y (n,b) or actin (c). (b) and (c) are adjacent sections; note the patchy express ion of IFN-y compared to actin. (n-c) Same magnification . Senle Iw', 60 
!Lm. (d) Flow cytometry of sup rabasal, differentiating keratinocytes isolated from epidcmlis of control (red) or transgenic (green, line 1212F) mice stained 
with an FITC-conjugated anti-1 FN- y antibody. The horizolltal lille indicates ce lls with fluorescence above background (determined by labebng with 
FITC-conjugated anti-CD8, not shown). )' axis: coun ts = celJ number. x axis: fluorescence (arbitrary units, log sca le). 
ated cells were not. No labeling of non transgenic keratinocytes was 
observed (Fig 1d and data not shown). 
The Transgenic Mice Have a Skin Phenotype That Is 
Detectable by Gross Inspection Although all mice appeared 
no rmal at birth , several m arked differences between transgenic and 
control animals were observed a few days later. By 8 d m any 
animals exhibi ted retarded hair growth and were smaller thaI) 
nontransgenic littermates (Fig 2a) . By 2 wk of age, all transgenic 
an imals exhibi ted hypopigmentation of the hair (Fig 2b,c) , with 
coat color eithe r gray (in mice segregating to the C57/BLlO 
background; Fig 2c) or yellow (in mice from the C BA agouti 
background; Fig 2b). 
In order to understand the cause of hypo pigmentation of the hair, 
we stained sections of transgenic mouse skin w ith DOPA to 
visualize the melanocytes. In back skin from 6.5-d-old control 
animals, all the hair bulbs and hair shafts were DOPA-positive, and 
there was no staining of the epidermis (Fig 2e). In contrast, DOPA 
stai.ning of 6.5-d-old transgenic back skin showed a considerabl e 
reduction in positivity in the hair follicles and persistence of 
m elanocytes in interfollicul ar epidern1is (Fig 21) . In adult transgenic 
mice DOPA staining of tail epidermis revealed very few tyrosinase-
containing melanocytes and little pigmentation of the keratinocytes 
(data not shown; but no te hypopigmentation of tails in Fig 2 a,d) . 
By 3 wk of age, the most severely affected animals (5-20% of 
transgenics, depending on the lin e) exhibited extreme erythema 
(reddening of the skin), severe growth retardation, hair loss over 
large areas of the trunk, and flaky and pustular lesions on the skin, 
especially around the joints of the appendages (Fig 2d) . M ore 
mildly affected animals ex hibi ted slight erythema and were occa-
sionally flaky at sites of friction (not shown). 
As the severely affected transgenic mice aged, many developed a 
hunched appearance and odd ga it. Upon internal examination, 
animals with the most severe skin phenotyp e (Fig 2d) had grea tly 
enlarged spleens (on average, twice the weight of control animals) 
and sm aller thymuses than control mice. We also observed that 
almost 50% of the animals that were mildly affected at 3 wk 
developed focally severe skin lesions by th e age of 1 y. The animals 
are of a mixed genetic background, and the penetrance of me 
severe skin phenotype may be due to a combination of genetic and 
en vironm ental factors. 
The Transgenic Mice Have AbnorD1al Skin Histology Skin 
from body sites of transgenic and age- and sex-matched non trans-
genic litterm ates was fixed, sectioned, and stained with hematox-
ylin and eosin or processed for electron microscopy (Fig 3) . In 
mildly affected transgenic animals (i.e ., hypopigmented hair, no 
gross inflammation or skin flakin g), there were striking alterations 
in the epidermis and dermis (Fig 3c,d, c.f. a,b). There was focal 
spongiosis (intercellular edema) in all livin g layers of the epidennis 
(Fig 3d) . Altho ugh the epidermis was not hyperplastic, the dermal 
capillari es were enlarged, and there was an inflammatory infiltrate 
in the dermis (Fig 3c) . 
In more severely affected animals (gross evidence of fl aking and 
inflammation), epidermal hyperplasia was evident, reflecting an 
increase in both the number of viable cell layers (acanthosis) and 
cornified layers (hyperkeratosis) (Fig 3eJ). T here were regions in 
which the cornified layers were nucl eated (parakeratotic), and there 
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Figure 2. Gross phenotype of transgenic mice. (n) Transgenic mouse (bOttolll; line 12050) and control (top) at 8 d of age. Notice the alopecia and 
reduced pigmentation of transgenic anima l. (b) Two-week-old transgenic (life; line 1205C) and control (Iighr) littermate showing agouti hair coat in the first 
hair cycle. Notice lighter coat co lor of transgenic. (c) Two-week- old transgenic (bottolll; line 120SC) and control (top) littcnnate. Notice gray coat color o f 
transgenic . (d) Three-week old transgenic (borrolll ; line 12050) and control (rop) littermate. Note retarded growth. alopecia. hypopigmencation. erythema. 
and flaking of skin of transgenic. (eJ) Dorsal skin from 6.5-d-old control (r) and transgenic if; line 12050) mice was stained with DOPA to visualize tyrosinase 
activity of melanocytes. Note the DOPA-positive cells in the epidermis and reduced DOPA staining of the hair follicles of transgenic skin . Senle bnr. 60 iLm . 
were occasional microabcesses in the cornified layers (Fig 3e). 
Electron microscopy of severely affected epidermis revealed severe 
spongiosis in all layers of the epidermis and a marked increase in the 
number of granular layers and number of keratohyalin granules per 
cell, except in regions of parakeratosis where the granular layer was 
absent (Fig 3.f). In some of the severely aflected mice, the epidemus 
was separated from the dermis at the level of the basement 
membrane. and there was infiltration of lymphocytes. macro-
phages. and monocytes into the space between epidernlis and 
dermis (Fig 3e) . 
Transgenic Keratinocytes Are Hyper-proliferative and 
Show Features of Abnormal Differentiation In order to 
assess the proliferative state of the epidemlis, skin sections were 
stained with an antibody to Ki67. a nuclear protein expressed by 
proliferating cells (c.f. Carroll et al. 1995) (Fig 4a,b). Slight 
increases in epidermal proliferation were noted in nilldly affected 
epidermis when compared with control epidermis (6.7% ± 0.7% 
Ki67-positive basal keratinocytes in control; 16.2% ± 3.4% in 
transgenic; data from individual representative aninlals). Thickened 
epidermis from severely inflamed animals showed a substantial 
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Figure 3. Abnormal histology o f transgenic mouse skin. Back skin from adu lt control (fI ,b). mildly afFected transgenks (r,d; line 120SC). or sevcrely 
affected transgenics (rtf; lin e 121 2F). Sk in was either sta ined with hematoxylin and eosin (fI,C,C) or processed fo r electron microscopy (b, dJ) . - in (c) show 
cnlarged dermal capi llari es . • in (c) shows split at dermo-epiderm al junction. Scale bar in (a): 60 ,.Lln. (a,c,c): same magnification. Scale bar in ((J): 8 I-'m. (b,d): 
same magnification. SCI/ II' (WI" in (1): 10 , .. un. 
in c rease in the number of K.i67- positive keratinocytes (64.4°;(, ::'::: 
12.2% K.i67-positive basa l cells). T he am ount of hype r-proliferation 
cOITelated broadly with th e le vel of dermal infiltrate. 
(31 integrin expression is normally confined to the basa l epider-
mal layer (Fig 4c) but is also suprabasaJ under conditions in w hich 
the epidermis is hyper-prolife rative (Carr o ll er aI, 1995, and refer-
e nces cited therein) . In mildly affected animals (data not shown) 
in tegrin express ion was restricted to the basa l layer. In severely 
inflamed mice w ith epide rmal thickening, however, exten sive 
suprabasa l (31 integrin expression was commonly o bserved (Fig 4d) . 
In normal epidermis, keratin 17 (K17) expressio n is confined to 
hair fo llic les, but K17 is de tected in in terfo lli cu lar ke ratinocytes in 
psoria tic les ions and is known to be indu ced by IFN-y (Vogel er aI, 
1995). Skin from contro l and transgenic mice was subjected to ill 
sir" hybridization with a probe for K17. While control mouse skin 
showed expression o nl y in hair follicles , transgenic e pide rm.is from 
even mildly affected anima ls showed hig h levels ofK17 expression 
in the basal la ye r (Fig 4eJ). Immunofl uorescence staining sbowed 
that epide rmis fro m even mildly affected animals expressed K6 and 
that there were no significant changes in K1 or [(14 expression in 
transgenic epidermis (data not shown) . 
Expression ofIFN-l' Receptor Is Decreased and Expression 
of ICAM-l and MHC Class II Molecules Is Induced in 
Transgenic Mouse Epidermis To in vestigate whether overex-
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Figure 4. Hyper-proliferation and aberrant gene expression in transgenic skin. Skin from control (a,c,e) or transgCIlic (b,dJ: line 1205D) anima ls. 
from either the back (a-d) or the lip (eJ), sta ined with anti-Ki67 antibody (n, b), anti-integrin /3, antibody (c,d), or hyb,iclized with 'iboprobe to K17 mRNA 
(eJ). In (e), note K17-positive hair follicles, but negati ve epidermis. Scale bar in (c,e): 60 f.Lm; (a-d): sam e magnification; (eJ): same magnification . 
pression of IFN-y resuJted in modulation of levels of the IfN-y 
receptor, skin was immul10stained with an antibody to the a -chain 
of the receptor. In normal mouse skin, the receptor was eA1Jressed 
on the surface of basal keratinocytes (Fig Sa), as reported previ-
ously for human epidermis (Scheynius et ai, 1992). In epidermis 
from most of the transgenic animals, surface staining for the fFN-y 
receptor was not detected in basa l or supra basal keratinocytes, 
although there was increased sta ining in the dermis (Fig 5b) . 
Upregulation of the receptor in supra basal and basal layers was 
sometim es observed in severely inflamed epidermis (data not 
shown). 
Skin sections were also stained with antibodies to MHC class II 
molecules and ICAM-1 , proteins that are known to be expressed on 
the surface of keratinocytes treated with IFN-y (Dustin et ai, 1988; 
Griffiths et ai, 1989). N o ICAM-l could be derected consistently in 
nomlaJ m Ollse epidermis (Fig 5c), but the basal layer of epidermis 
from all transgenic mice exa min ed stained positively for ICAM-l 
(Fig 5d) . Focal areas of suprabasal ICAM-l could also be observed 
in severely inflamed animals (data not shown) . In nonna] mouse 
skin , only resident Langerhans cells stained positively for surface 
MHC class " molecules (Fig 5e). AIl layers of the epidermis of 
transgenic animals, however, stained positively for surface MHC 
class II molecules (Fig 5./) . Control and transgenic keratinocytes did 
not sta.in positive with an antibody to murin e 87-1 (data not 
shown) . 
Transgenic Mice Show an Inllnune Response Skin fi'om 
transgenic and control mice was stained with a range of antibodies 
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Figure 5. Expression of the IFN-y recep-
tor, ICAM-l and MHC class II in control 
and transgenic epidermis. Dorsal skin from 
control (a,c,e) or transgenic (b,dJ; line 1205D) 
mice. Stained with antibody to IFN-')' receptor 
(a,b). ICAM-l (c, d) . or MHC class II (eJ) . Scale 
bar (e): 60 f.Lm. 
to immune cells in order to characterize the nature of the inflam-
matory response. In normal skin staining with an antibody to Mac1 
(CDll b). a marker of cells of the macrophage/monocyte lineage, 
revealed scattered Langerhans cells (dendritic in morphology) in 
the epidermis and dennis (Fig 6a) . In inflamed transgenic mouse 
skin no Mac1-posi.tive cells were found in the epidermis, but there 
was extensive staining of the dermis (Fig 6b). 
Loss of Langerhans cells from the epidermis of transgenic mice 
was confirmed by experiments with antibody NLDC-145. a marker 
of non lymphoid dendritic cells. including Langerhans cells . Epider-
mis from transgenic and control mice was disaggregated, stained 
with NLDC-145, and subjected to flow cytometry. In control 
epidermis 4.3 ± 0.98% of cells were NLDC-145-positive, whereas 
no positive cells were found in transgenic epidennis (whether mild 
or severe phenotype) . Because Langerhans cells, which leave the 
epidermis during an acute inflammatory response, are known to 
migrate to the lymph nodes to present antigen (van Wilsem et ai, 
1994), inguinal lymph nodes from control and transgenic mice were 
stained with NLDC-145 and subjected to flow cytometry. Inguinal 
lymph nodes of transgenic mice showed a constitutively high level 
of Langerhans cells (42 .3% ± 6.3% NLDC-145-positive cells; 
mean ± SD from four mildly affected mice) when compared to 
control mice (5.4% ± 0.8% NLDC-145-positive cells; mean ± SD 
from four mice). The increase in NLDC-145-positive cells in the 
lymph nodes could either be due to migration from the epidermis or 
to increased production of dendritic cells within the animals. 
The skin was also stained with antibodies to the pan-T lympho-
cyte marker, CD3. Immunofluorescent staining of transgenic skin 
revealed an increase in dermal CD3-positive cells, but a significant 
decrease in epidermal CD3-positive cells (Fig 6d) relative to 
control skin (Fig 6c). Broadly, a loss of lymphocytes from the 
epidermis was correlated with an increase in epidermal thickness 
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and hyperplasia. To quantitate this difference, epidermis from 
severely affected transgenic mice and control mice was disaggre-
gated, labeled with anti-CD3. and subjected to flow cytometry. 
The proportion of CD3-positive cells in transgenic epidennis was 
0.51 ± 0.24%, compared with 1.6 ± 0.47% in control epidermis 
(mean ± SD from four mice per group). Labeling with anti-CD4 
established that there were no CD4-positive lymphocytes in control 
epidermis, but approxinlately 7% of lymphocytes i.n transgenic 
epidermis (severely inflamed) were CD4-positive. 
Because IFN-y is known to induce autoantibody production (Gu 
et ai, 1995; Lee e/. aI, 1995), we tested whether serum from control 
or transgenic' mice would stain sections of normal mouse skin. 
Serum from transgenic mice (whether mild or severe), but not 
control mice. intensely stained keratinocytes in both basal and 
suprabasal layers of nontransgenic epidermis (Fig 6 eJ). The 
staining patterns were frequently nuclear (Fig 6.1). and the nature of 
the antigens is currently under investigation (Seery et aI, in prepa-
ration). Immunoreactivity was observed in skin from all body sites 
at a serum dilution of 1:10. 
Increased Contact Hypersensitivity in Transgenic Mice 
Application of contact sensitisers to the epidermis stimulates a T 
lymphocyte-mediated immune response that . can be assessed by 
subsequent challenge with the same hapten. We investigated 
whether mildly affected IFN-y transgenic mice showed an in-
creased immune response in a contact hypersensitivity experiment. 
Ears of mice transgenic for IFN-y were thicker than control ears 
prior to addition ofDNFB, due to constitutive edema (0.47 ± 0.09 
mm in transgenic line 1205C compared to 0.30 ± 0.02 mm in 
controls (data from five animals · in each group). Significantly, the 
abdomen oflFN--y transgenic mice exhibited an acute local inflam-
matory response to the sensitizing dose of DNFB whereas control 
i 
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mice did not (data not shown). Transgenic mice showed a signifi-
cantly increased hypersensitivity response to DNFB 6 h after 
application when compared to control Iittermates (Fig 7a) . In 
control mice, ear thickness had returned to nonnal after 48 h; 
however, in IFN-y transgenics, swelling had not declined signifi-
cantly after 72 h, the final time point examined. Sections of ears 
72 h after DNFB treatment are shown in Fig 7b,c: the nontrans-
genic ear is indistinguishable fi'om an untreated ear, whereas tlle 
transgenic ear shows persistent edema and dilated blood vessels. 
As a control for these experiments, ear thickness was also 
deternlined in mice that received an application ofDNFB to the ear 
without prior sensitization (Fig 70) . No swelling was observed in 
the ears of non transgenic mice. Transgenics showed ear swelling, 
but it was not as great as in sensitized transgenic mice, and 
maxinlum swelling did not occur until 48 h. 
DISCUSSION 
Expression of IFN-y under the control of the involucrin promoter 
in transgenic mice resulted in dramatic changes in the skin that are 
consistent with the known role of IFN-y as a potent modulator of 
immune responses (reviewed by Williams et ai, 1993). The changes 
in the epidermis, i.e., spongiosis, acanthosis, and parakeratosis, and 
changes in dermis, i.e., blood vessel dilation, edema, and infiltra-
tion of lymphocytes and monocytes, are all features of eczema 
(Hopkins and Clark. 1995). In addition, the mice exhibited in-
creased contact hypersensitivity and had hypopigmentation of the 
hair, with alopecia in severely affected animals . 
Hair pigmentation appeared to be caused by reduction in the 
number of DOPA-positive melanocytes in the hair follicles, sug-
gesting tllat overexpression of IFN-y in the skin may inhibit 
melanocyte proliferation or induce apoptosis . In normal mouse 
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Figure 6. Immune profiles of transgenic 
mice. Skin from the back (a-d) or tail (cJ) of 
control (a,c,eJ) or transgenic (b,d) mice was 
sectioned and stained with: anti-Mac1 
(CDItb) (a,b). anti-CD3 (c,d), or serum from a 
nontransgcnic (c) or severely inflamed trans-
genic mouse (f; line 120SD). Notice the stain-
ing of control keratinocytes in both basal and 
suprabasal layers with serumfroll1 transgenic 
mice lj). Scale bar (c): 60 J.l.Il1. 
interfolliculal' epidernus there are vinually no DOPA-positive 
melanocytes at binh; within 2 d the number starts to rise and then 
declines within 1 wk (Fig 2; Okura et ai, 1995); although DOPA-
positive melanocytes were absent from the epidenuis of adult 
transgenics, they were readily detectable at birth and persisted for 
longer than in the controls, suggesting that IFN-y may have 
additional effects, e.g., on melanocyte nugration (cf. Okura et ai, 
1995) . 
Although n1.ice with hypopigmented hair have been observed 
previously, e.g., in aninlals lacking bcl-2 (Yamamura et ai, 1996) or 
injected with antibodies to c-kit (Okura et ai, 1995), tile IFN-y 
transgelucs are the first to establish a causal link between a cytokine 
and a pigmentation defect. It is therefore interesting to note the 
existence of some human conditions in which inflammatory skin 
disease is associated with depigmentation (vitiligo) (von den 
Driesch et ai, 1992; Arata and Abe-Matsuura, 1994). 
Some of the keratinocyte changes observed are probably a direct 
response of the cells to IFN-y. Thus IFN-y is known to induce 
MHC class II, ICAM-1, and keratin 17 expression by keratinocytes 
ill vitro and ill IIivo (Dustin ei ai, 1988; Bal'ker et aI, 1989; Griffiths e/ 
ai , 1989; Barker et ai, 1990; Vogel e/ ai, 1995). The downregulation 
of expression of tile IFN-y receptor is likely to be a consequence of 
overexpression of tile ligand, because downregulatioll of the EGF 
receptor has been observed in transgeluc mice overexpressing 
transfornung growth factor- a (TGFa) (Dominey et ai, 1993) . 
Transgenic mice expressing ICAM-1 in the epidermis do not have 
a spontaneous inflammatory phenotype, ruling out a role for 
ICAM-l as a primary inducer ofinflanlmation in the skin (Williams 
and Kupper, 1994). 
The stimulation of keratinocyte proliferation and induction of 
keratin 6, frequently fowld in hyper-proliferative epidermis, are 
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Figure 7. Increase d contact hypersensitivity response of trans-
genic mice. (a) Ear swelling o f control (<> , 6 ) or transgenic (0, 0) mice at 
va rio us times afte r D N FB appli catio n to car skin. As a contro l some mice 
(6,0) did not receive a scnsitiz iJlg dose o f D N FB prior to ea r applica ti on. 
Each poin t represents mean :±: SO from fo ur mke, w ith means being deri ved 
from m easuremen ts taken at three di ffe rent places on each mo use ear. (b,c) 
Histology of cars of control (b) or transgenjc (c) mice 72 h after appli cation 
ofDN FB. N ote the increased thjckness of the transgenic ea r and the dil ated 
blood vessels. Senle bar (b): 60 f.Lm . 
p robabl y an indirec t e ffect o f IFN-1' beca use fFN -1' inhibits proli f-
eration of norm al keratinocytes in culture (Nicko loff ef ai, 1989) . 
Instead , they may reAect upregul ati on of expression of other 
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cytokines and gro wth factors in response to IFN-1' (review ed by 
Barker ef ai, 1. 991) . A reduced inhibi toL), effec t o f IFN-1' on 
keratin ocyte proliferation is correlated w ith upregulated TGFa: 
productio n (Nickoloff ct aI, 1989), and overexpressio n o f T GFa in 
transgeni c m ouse epidermis leads to epidermal hyperplasia and 
indu ctio n of K6 (Vassar and Fuchs, 1991; D o miney ef aI, 1993) . 
W hen IFN -1' is u1iected into hum an skin , there is also an increase 
in keratinocyte proliferatio n and induction of K1 6, the keratin 
partner ofK6 (Barker e/ ai, 1993) . 
All the transgenic mice had epidermal sp ongiosis and in severely 
affected mice th ere w ere regions of detachment of the epidermis 
£i'om the dermis w ith an inAux o f immune cell s into the resulriJlg 
space. It is in terestin g that IFN -1' uljection o f human skin results in 
accumulation o f lymphocytes at the basemen t m embrane zone 
(Barker et ai , 1989) , and that injectio n of IFN-a: for clinical 
purposes can induce autoantibodies and pemphigus-like lesions 
(Niizeki e( ai, 1994 and references cited therein) . Because we did 
not de tec t IFN-1' in the blood we do no t have evidence for transfer 
o f IFN-1' across the basem ent m embrane. Some of th e dem131 
changes, such as edema , could al so be due to IFN-I'- stimulated 
release of other mo lecules, for example, nitric oxide (Heck et al 
1992; Schmidt and W alter, 1994). 
R es ting T lymphocytes require tw o ac tivation signals in order to 
prolifera te and release cytokines (re vie wed by Nickoloff and Tur ka, 
1994) . T he first signal com es from T - cell receptor recognition of 
an tigens bound to the appropriate MHC class II molecule, and the 
second is pro vided by B7 bUldulg to its ligand o n the T -lymphocyte 
surface. Engagem ent of the T - cell receptor on restin g T cells in the 
absence of co-stinllliation via B7 m ay induce clonal anergy, possibly 
resulting in lymphocyte death . T he absence o f a co-stimulatory 
signal may be the expl anation for the reduced T lymphocytic 
infil trate in the epidermis o f the IFN-1' tran sgenic mice because 
B7-1 w as no t de tected on the surface o f the transgenic keratino-
cytes; indeed , it has been demonstrated that keratinocytes can 
provide an anergic signal to T cells (B al el ai, 1990) . Anergy would 
also explain wh y there w as no T lymphocyte-mediated des truction 
o f kera ti.nocytes, Ul contras t to the killing ofIslet ceUs in transgen.ic 
mice overcxp ressing IFN-1' in the pancreas (Sarvetnick e( aI, 1990). 
Any inabili ty of keratinocytes to activa te T cells caJUlot be due 
solely to lack of expressio n of co-stimulatory molecules because 
epidermal expression ofB7-1 in transgenic mice is no t sufficient to 
induce T lymphocyte ac ti va tion , even w hen th e B7-1 mice are 
uljec ted with IFN-1' to indu ce MHC class II o n keratinocytes (Nasir 
et ai, 1994; William s et aI, 1994) . 
T he infiltration of macrophages ,1Ild m onocytes into the dermis 
of the transgenic mi ce w as to be expected , given the we ll estab-
lished ro le o f IFN-1' as an indu cer of di'fferen tiation and ac ti va tion 
of cells of the m yeloid lineage; furth er cytokine release by myeloid 
cells would then lead to the inAux of lymphocytes (Schul tz and 
Klein schmidt; 1983; T rinchjeri and Pcruss ia, 1985). W e speculate 
th at one consequence o f the infil tratio n o f myeloid and lymphoid 
cells m ay be hair loss as a result o f immune attack (Baadsgaard, 
1991) . M.icc lackillg the f36 integrin subunit have juvenile baldness 
associa ted with macrophage infil tration of the skin (Huan g e( ai, 
1996) . Interes tulgly, elevated IFN-1' expression has been reported 
in the human condition alopecia areata (Hofl:in alUl ct ai, 1994) . 
La ngerhan s cell s are the majo r antigen-presenting cells of tbe 
epidermis. In contact hypersensitivi ty reactions, Langerhan s cells 
move to the lymph nodes and p resent an tigen to residen t T cells 
(van Wilsem et ai , 1994) . Our mice appear to show tlus migration 
in the absence of DNFB, and the response to DNFB w as more 
sustained and dramatic than the !'espo nse Ul con tro l mice . Injection 
of high concentrations of IFN-1' in to human skill also results in 
deple tion of Langerhan s cells fro m th e epidermis (Barker et ai, 
1990) . 
T here is mu ch evidence to sugges t a primary role for IFN-1' Ul 
m ediating contact hypersensitivi ty reactions. IFN-1' expression is 
increased in contact hyp ersensiti vity (Kondo cl aI, 1994), and it has 
recently been found tb at keratinocytes in patients wi th allergic 
contac t dermatitis are indu ced to express IFN-1' when ch allenged 
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with allergen (Howie e/ ai, 1996). Mice lacking the IFN-y receptor 
show a diminished contact hypersensitivity response (Saulnier et ai, 
1995), and anti-IFN-y partially inhibits ear swelling in contact 
hypersensitivity (Piguet et ai, 1991). The suppressive effect of 
interleukin-10 on contact hypersensitivity is correlated with sup-
pression ofIFN-y production (Kondo et ai, 1994). Another fact that 
supports a role ofIFN-y in contact hypersensitivity reactions is that 
IFN- y is produced by the T-cell subpopulation that predotninates 
in delayed-type hypersensitivity reactions (Noelle and Snow, 
1992). 
How does the phenotype of the IFN-y transgenic mice compare 
with known hwnan inflammatory skin diseases? Although IFN-y 
has been proposed to play a central role ill the pathogenesis of 
psoriasis (Griffiths and Voorhees, 1992) the skin of the IFN-y 
transgenic mice is quite difterent from human psoriatic skin or from 
that of transgenic mice in which suprabasal integrin ell.-pression 
results in psoriasis-like lesions (Carroll et aI, 1995 and references 
cited therein): for example, in pSOliasis there is an influx of 
lymphocytes into the epidennis and there is no spongiosis. Al-
though the IFN -y transgenics have clear characteristics of eczema, 
the observed phenotype is distinct from the form of eczema known 
as atopic dermatitis, wh.ich has a strong genetic component and 
tends to be associated with respiratory problems such as asthma. In 
atopic dermatitis there is hyperplasia of Langerhans cells in the 
epidermis (Barker el ai, 1988), and 1FN- y is used as a form of 
therapy in order to reduce 19E production (Gruner el ai, 1990). III 
contrast, our mice appear to have the form of eczema referred to as 
contact dermatitis in which diverse environmental stimuli induce 
cutaneous inflammation. 
In contact dermatitis it has long been recognized that keratino-
cytes respond to environmental stimuli by secreting cytokines such 
as TNFa and interleukin-1, which in tum activate dermal endo-
thelial celis, leading to recruitment of T lymphocytes from the 
circulation. Interaction of T cells with keratinocytes is believed to 
cause an amplification of the inflammatory process, with IFN-y 
release inducing expression of ICAM-1 and MHC class II by 
keratinocytes and triggering autoCl'ine production of keratinocyte 
growth factors including TGFa. Growth factors such as TGFa are 
strongly implicated as the agents that lead to keratinocyte hyper-
proliferation in demlatitis (reviewed by Barker et ai, 1991) . 
One prediction of tlus model is that transgenic nuce in wluch 
interleukin-1 or TNFa, cytokines 'upstream' of IFN-y in the 
inflammatory response, is expressed in the epidermis should have a 
sinillar phenotype to the IFN-y transgenics. Transgenic nuce 
expressing interleukin-1a are indeed strikingly sinillar to the IFN-y 
transgenics (Groves e/ ai, 1995), but the TNFa mice develop 
graft-,}ersl/s-host disease leadi.ng to necrosis of the skin (Cheng et ai, 
1992). An obvious limitation of these transgenic mice is that 
although any given cytokine can be targeted to the tissue of interest 
it is not possible to minuc the temporal changes in ell.-pression that 
occur during contact dermatitis . Nevertheless, the IFN-y mice do 
firmly establish a m;uor role for IFN-y in i.nflammatory skin disease, 
and by crossing them with transgenics in wluch other aspects of the 
immune system have been targeted we may gain a more complete 
understanding of eczema. 
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